HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dermatology
RCT
Phase 2 trial finds topical STS01 1% improves SALT scores in patchy alopecia areata.
A New Topical Treatment Shows Promise for Patchy Hair Loss
A phase 2 randomized controlled trial in 155 adults with mild to moderate patchy alopecia areata found that daily topical STS01 1% for 6 mon…
A new, easy-to-apply cream could offer a much-needed treatment option for a common and distressing form of autoimmune hair loss.
medRxiv
Apr 11, 2026
Dermatology
RCT
Phase 2 trial: Topical STS01 shows dose-related hair regrowth in mild-moderate alopecia areata
Topical treatment shows hair regrowth in alopecia areata, but quality of life unchanged
A Phase 2 randomized controlled trial in patients with mild to moderate patchy alopecia areata found that topical STS01 (dithranol) produced…
A new topical treatment regrows hair in patchy alopecia, yet patients report no improvement in daily life or feelings even with full regrowt…
medRxiv
Apr 4, 2026